Structure via PubChem · Public domain (PubChem)
tazarotene
Sign in to saveAlso known as AGN-190168, Tazorac®, Zorac®, Tazaroteno, Tazarotenum
Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid. It is primarily used for the treatment of plaque psoriasis and acne. Tazarotene is also used as a therapeutic for photoaged and photodamaged skin. It is a member of the acetylenic class of retinoids.
Key facts
- Drug.image
- Tazarotene.png
- Drug.image_class
- skin-invert-image
- Drug.alt
- Skeletal formula of tazarotene
- Drug.width
- 240
- Drug.image2
- Tazarotene-3D-spacefill.png
- Drug.image_class2
- bg-transparent
- Drug.alt2
- Space-filling model of the tazarotene molecule
- Drug.tradename
- Tazorac, Arazlo, Fabior, others
- Drug.MedlinePlus
- a616052
- Drug.DailyMedID
- Tazarotene
- Drug.routes_of_administration
- Topical
- Drug.ATC_prefix
- D05
- Drug.ATC_suffix
- AX05
- Drug.ATC_supplemental
- (combination with ulobetasol)
- Drug.legal_CA
- Rx-only
- Drug.legal_CA_comment
- /Schedule D
- Drug.legal_US
- Rx-only
- Drug.legal_status
- Rx-only
via Wikipedia infobox
Chemical data
- Formula
- C21H21NO2S
- Molecular weight
- 351.5 g/mol
- IUPAC name
- ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate
- SMILES
- CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
- InChIKey
- OGQICQVSFDPSEI-UHFFFAOYSA-N
- XLogP
- 4.9
- Polar surface area
- 64.5 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1997
- Admin. routes
- topical
- Indications
- acne, psoriasis, skin disease, Cutaneous T-cell lymphoma
via ChEMBL · EBI
Research
752 papers- Tazarotene.2006
- Tazarotene.Drugs · 1998
- Tazarotene 0.045% Lotion: A Novel Retinoid Formulation.The Annals of pharmacotherapy · 2022
- GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing.Journal of nanobiotechnology · 2022
- Pharmacokinetics of tazarotene and acitretin in psoriasis.Expert opinion on drug metabolism & toxicology · 2018
via PubMed
~6 min read
Encyclopedic overview
12 sectionsContents
- Medical uses
- Available forms
- Contraindications
- Pregnancy
- Adverse effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Synthesis
- Research
- Melanoma
- References
Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid. It is primarily used for the treatment of plaque psoriasis and acne. Tazarotene is also used as a therapeutic for photoaged and photodamaged skin. It is a member of the acetylenic class of retinoids.
Tazarotene was approved for medical use in 1997 and is available as a generic medication.
Excerpted from Wikipedia’s “tazarotene” article, available under the CC BY-SA 4.0 licence.
Gallery (3)
Available in 15 languages
- Español
- Français
- 中文
- Italiano
- العربية
- azb
- Bahasa Indonesia
- Odia
- Serbian
- Serbian (Latin)
- Tiếng Việt
- Türkçe
- Welsh
- فارسی
via Wikidata sitelinks · CC0